| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/01/2001 | WO2001007612A2 Receptors and associated proteins |
| 02/01/2001 | WO2001007611A2 Novel polynucleotides and method for the use thereof |
| 02/01/2001 | WO2001007607A2 FULL LENGTH cDNA CLONES AND PROTEINS ENCODED THEREBY |
| 02/01/2001 | WO2001007601A2 Method for conferring herbicide, pest, or disease resistance in plant hosts |
| 02/01/2001 | WO2001007600A1 Method of correlating sequence function by transfecting a nucleic acid sequence of a donor organism into a plant host in an anti-sense or positive sense orientation |
| 02/01/2001 | WO2001007596A1 Arabidopsis thaliana cyclic nucleotide-gated ion channel/dnd genes; regulators of plant disease resistance and cell death |
| 02/01/2001 | WO2001007595A2 Novel fibroblast growth factor and nucleic acids encoding same |
| 02/01/2001 | WO2001007593A1 Dna chip |
| 02/01/2001 | WO2001007583A1 Cell/tissue analysis via controlled electroporation |
| 02/01/2001 | WO2001007581A1 Method for encapsulating macromolecules and/or particles and use thereof |
| 02/01/2001 | WO2001007574A2 Modified cytochrome p450 monooxygenases |
| 02/01/2001 | WO2001007573A1 Electron donor system for enzymes and its use for the biochemical conversion of substrates |
| 02/01/2001 | WO2001007483A1 Prognosis and therapy of malignant diseases by antibodies which bind phosphorylated met protein |
| 02/01/2001 | WO2001007481A1 Antitumor antibodies, proteins, and uses thereof |
| 02/01/2001 | WO2001007476A1 26 human prostate and prostate cancer associated proteins |
| 02/01/2001 | WO2001007471A2 Cell cycle and proliferation proteins |
| 02/01/2001 | WO2001007470A2 Human nervous system-associated proteins |
| 02/01/2001 | WO2001007464A1 Even length proportional amplification of nucleic acids |
| 02/01/2001 | WO2001007463A1 Trer |
| 02/01/2001 | WO2001007459A1 29 human secreted proteins |
| 02/01/2001 | WO2001007457A1 Antisense modulation of pten expression |
| 02/01/2001 | WO2001007454A1 Enzyme catalyzed therapeutic activation |
| 02/01/2001 | WO2001007451A2 Isolation of biomolecules |
| 02/01/2001 | WO2001007159A2 Integration of biochemical protocols in a continuous flow microfluidic device |
| 02/01/2001 | WO2001007088A2 Methods for treating therapy-resistant tumors |
| 02/01/2001 | WO2001007087A2 Enzyme catalyzed anti-infective therapeutic agents |
| 02/01/2001 | WO2001007070A1 Method for measuring coagulant factor activity in whole blood |
| 02/01/2001 | WO2001007066A2 Ppar delta inhibitors for the treatment of cardiovascular diseases |
| 02/01/2001 | WO2001007034A1 Multidrug resistance pump inhibitors and uses thereof |
| 02/01/2001 | WO2001007030A2 Compositions an inhibitor of an accrab-like efflux pump for reducung microbial resistance to drugs |
| 02/01/2001 | WO2001006910A2 VARIATION IN DRUG RESPONSE RELATED TO POLYMORPHISMS IN β2- ADRENERGIC RECEPTOR |
| 02/01/2001 | WO2000068415A3 A method for measuring biomolecules |
| 02/01/2001 | WO2000066722B1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof |
| 02/01/2001 | WO2000063352A3 Human homologues of fused gene |
| 02/01/2001 | WO2000061728A3 Human elastase i |
| 02/01/2001 | WO2000061724A3 Anti-bacterial vaccine compositions |
| 02/01/2001 | WO2000059917A3 Information-carrying and information-processing polymers |
| 02/01/2001 | WO2000058503A3 Improved method for detecting micro-organisms |
| 02/01/2001 | WO2000053742A3 Polynucleotides and proteins encoded thereby |
| 02/01/2001 | WO2000053733A3 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 02/01/2001 | WO2000052479A3 Diagnostics and therapeutics for drusen associated ocular disorders |
| 02/01/2001 | WO2000049043A3 Human lipid-associated proteins |
| 02/01/2001 | WO2000044906A3 GENES IDENTIFIED AS REQUIRED FOR PROLIFERATION IN $i(ESCHERICHIA COLI) |
| 02/01/2001 | WO2000043781A3 Growth differentiation factor inhibitors and uses therefor |
| 02/01/2001 | WO2000037493A3 Type iii secretion system antigens from bordetella pertussis |
| 02/01/2001 | WO2000015838A3 Essential genes from c. albicans and a method for screening antimycotic substances using said genes |
| 02/01/2001 | WO2000008041A9 Structural analogs of amine bases and nucleosides |
| 02/01/2001 | WO1999018192A8 Methods for the identification and production of swine with reduced boar taint |
| 02/01/2001 | DE19935967A1 New DNA encoding Arabidopsis thaliana 1-deoxy-D-xylulose-5-phosphate reductoisomerase for identifying modulators of the enzyme that can be used as herbicides, antibiotic or anti-malarial agents |
| 02/01/2001 | DE19935767A1 Selection of primer pairs for reverse transcription amplification, based on low homology between mRNA and pseudogene sequences, provide specific amplification of cDNA |
| 02/01/2001 | DE19935766A1 Verfahren zur optischen Anregung von Fluorophor-markierter DNA und RNA A method for optical excitation of the fluorophore-labeled DNA and RNA |
| 02/01/2001 | DE19935115A1 Cytochrome P450 monooxygenase for oxidizing organic compounds, useful especially for converting indole to indigo, has wide substrate range |
| 02/01/2001 | DE19935113A1 Epoxidhydrolasen aus Streptomyces Epoxide hydrolases from Streptomyces |
| 02/01/2001 | DE19935088A1 DNA-Sequenzen, die sich zum spezifischen Nachweis von Pseudomonas putida KT2440 eignen DNA sequences that are suitable for the specific detection of Pseudomonas putida KT2440 |
| 02/01/2001 | DE19932890A1 DNA zum Nachweis von Veränderungen des Chromosoms 8 DNA for the detection of changes of chromosome 8 |
| 02/01/2001 | CA2718926A1 Methods of reducing microbial resistance to drugs |
| 02/01/2001 | CA2396591A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 02/01/2001 | CA2391824A1 Detection of human hepatitis b virus surface antigen mutants by specific amplification and its application on gene chip |
| 02/01/2001 | CA2383690A1 29 human secreted proteins |
| 02/01/2001 | CA2380363A1 Method for conferring herbicide, pest, or disease resistance in plant hosts |
| 02/01/2001 | CA2380330A1 Method of correlating sequence function by transfecting a nucleic acid sequence of a donor organism into a plant host in an anti-sense or positive sense orientation |
| 02/01/2001 | CA2380317A1 Human synthetases |
| 02/01/2001 | CA2380270A1 26 human prostate and prostate cancer associated proteins |
| 02/01/2001 | CA2380238A1 Homogeneous fluorescence method for assaying structural modifications of biomolecules |
| 02/01/2001 | CA2380226A1 Novel fibroblast growth factor and nucleic acids encoding same |
| 02/01/2001 | CA2380203A1 A two stage method for detecting single nucleotide polymorphisms (snps) |
| 02/01/2001 | CA2380198A1 Improvements in and relating to forensic investigations |
| 02/01/2001 | CA2380179A1 Methods for identifying cellular responses attributable to signaling molecule inhibition and inhibitors thereof |
| 02/01/2001 | CA2380171A1 Transposon mediated differential hybridisation |
| 02/01/2001 | CA2379927A1 Integration of biochemical protocols in a continuous flow microfluidic device |
| 02/01/2001 | CA2379834A1 Enzyme catalyzed anti-infective therapeutic agents |
| 02/01/2001 | CA2379818A1 Catalytic anti-factor viii allo-antibodies |
| 02/01/2001 | CA2379801A1 Receptors and associated proteins |
| 02/01/2001 | CA2379784A1 Cell cycle and proliferation proteins |
| 02/01/2001 | CA2379659A1 Antisense modulation of pten expression |
| 02/01/2001 | CA2379518A1 Electron donor system for enzymes and its use for the biochemical conversion of substrates |
| 02/01/2001 | CA2378898A1 Method for measuring coagulant factor activity in whole blood |
| 02/01/2001 | CA2378569A1 Method for relative quantization of methylation of cytosin-type bases in dna samples |
| 02/01/2001 | CA2378528A1 Computer-assisted formulation of culture media |
| 02/01/2001 | CA2378462A1 Ppar delta inhibitors for the treatment of cardiovascular diseases |
| 02/01/2001 | CA2378403A1 Novel polynucleotides and method for the use thereof |
| 02/01/2001 | CA2378110A1 Cell/tissue analysis via controlled electroporation |
| 02/01/2001 | CA2378107A1 <i>arabidopsis thaliana</i> cyclic nucleotide-gated ion channel/<i>dnd</i> genes; regulators of plant disease resistance and cell death |
| 02/01/2001 | CA2377810A1 Method for marking solid, liquid and gaseous substances |
| 02/01/2001 | CA2375606A1 Spatially-encoded analyte detection |
| 02/01/2001 | CA2375571A1 Human nervous system-associated proteins |
| 01/31/2001 | EP1072889A1 Method for assaying creatine kinase isozyme activity and assay reagent |
| 01/31/2001 | EP1072687A2 Method for testing metastatic potential and method for screening compounds with metastasis-suppressing activity |
| 01/31/2001 | EP1072686A2 Method for 5'-cap dependant cDNA enrichment |
| 01/31/2001 | EP1072683A1 Process for producing isoprenoid compounds by using microorganisms and method for detecting compounds having antibacterial or herbicidal activity |
| 01/31/2001 | EP1072680A1 Myostatin regulatory region, nucleotide sequence determination and methods for its use |
| 01/31/2001 | EP1072679A2 Method of producing nucleic acid molecules with reduced secondary structure |
| 01/31/2001 | EP1072678A1 Method for synthesizing dna |
| 01/31/2001 | EP1072677A1 Hybridoma cell line derived from 2.4G2 cell line, preferentially not expressing any mouse kappa chains |
| 01/31/2001 | EP1072010A2 Oligonucleotide mediated nucleic acid recombination |
| 01/31/2001 | EP1072006A1 Expert system for analysis of dna sequencing electropherograms |
| 01/31/2001 | EP1071959A2 Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway |
| 01/31/2001 | EP1071957A1 Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof |
| 01/31/2001 | EP1071955A1 Improved immunodiagnostic assays using reducing agents |
| 01/31/2001 | EP1071952A1 I kappa b and enhanced green fluorescent fusion protein |